AMB Surgical is an early-stage medical device product developer that holds two issued patents for an electro-mechanical automated growing rod called “Flyte”.
The clinical applications for Flyte are focused in high-need niche markets of Trauma and Spine. The $1.4 B addressable market of these niche segments have recently been demonstrated by the growth of Ellipse Technologies (competing IP) and its acquisition of by NuVasive for $380MM+. AMB is seeking $1M to validate design and performance, initiate regulatory pathways to attract commercialization partners and exit opportunities.